Cengild Medical Berhad

KLSE:CENGILD Stock Report

Market Cap: RM 212.4m

Cengild Medical Berhad Past Earnings Performance

Past criteria checks 1/6

Cengild Medical Berhad has been growing earnings at an average annual rate of 13.8%, while the Healthcare industry saw earnings growing at 18.6% annually. Revenues have been growing at an average rate of 3.7% per year. Cengild Medical Berhad's return on equity is 10%, and it has net margins of 15.2%.

Key information

13.8%

Earnings growth rate

-93.7%

EPS growth rate

Healthcare Industry Growth31.5%
Revenue growth rate3.7%
Return on equity10.0%
Net Margin15.2%
Last Earnings Update31 Dec 2024

Recent past performance updates

Cengild Medical Berhad's (KLSE:CENGILD) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jun 04
Cengild Medical Berhad's (KLSE:CENGILD) Weak Earnings May Only Reveal A Part Of The Whole Picture

Recent updates

Cengild Medical Berhad's (KLSE:CENGILD) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jun 04
Cengild Medical Berhad's (KLSE:CENGILD) Weak Earnings May Only Reveal A Part Of The Whole Picture

Cengild Medical Berhad (KLSE:CENGILD) Might Have The Makings Of A Multi-Bagger

Apr 05
Cengild Medical Berhad (KLSE:CENGILD) Might Have The Makings Of A Multi-Bagger

Investors Can Find Comfort In Cengild Medical Berhad's (KLSE:CENGILD) Earnings Quality

Sep 01
Investors Can Find Comfort In Cengild Medical Berhad's (KLSE:CENGILD) Earnings Quality

A Look At The Fair Value Of Cengild Medical Berhad (KLSE:CENGILD)

Aug 31
A Look At The Fair Value Of Cengild Medical Berhad (KLSE:CENGILD)

Revenue & Expenses Breakdown

How Cengild Medical Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KLSE:CENGILD Revenue, expenses and earnings (MYR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 247612220
30 Sep 247211200
30 Jun 246711190
31 Mar 246612180
31 Dec 236712180
30 Sep 237013170
30 Jun 237013160
31 Mar 237215150
31 Dec 227013140
30 Sep 226712140
30 Jun 22649140
31 Mar 22647150
31 Dec 21638140
30 Sep 21629130
30 Jun 216310120
30 Jun 20394100
30 Jun 1928190
30 Jun 1812-470

Quality Earnings: CENGILD has a high level of non-cash earnings.

Growing Profit Margin: CENGILD's current net profit margins (15.2%) are lower than last year (17.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CENGILD's earnings have grown by 13.8% per year over the past 5 years.

Accelerating Growth: CENGILD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CENGILD had negative earnings growth (-4.3%) over the past year, making it difficult to compare to the Healthcare industry average (-7.1%).


Return on Equity

High ROE: CENGILD's Return on Equity (10%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/15 18:59
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cengild Medical Berhad is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hock Lon ChiaRHB Investment Bank
Kong TanTA Securities Holdings Berhad